A Prospective, Randomized, Double-Blind, Parallel-Group Study to Compare the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Subjects with Essential Hypertension
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2016
At a glance
- Drugs Eprosartan (Primary) ; Hydrochlorothiazide
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Feb 2013 Planned number of patients changed from 596 to 665 as reported by EudraCT.
- 20 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.